The added value of serologic testing: A comparison of influenza incidence among pregnant persons based on molecular-based surveillance versus serologic testing.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511 (Electronic) Linking ISSN: 12019712 NLM ISO Abbreviation: Int J Infect Dis Subsets: MEDLINE
    • Publication Information:
      Publication: Hamilton, ON : Elsevier
      Original Publication: Hamilton, ON : Decker, c1996-
    • Subject Terms:
      Influenza, Human*/epidemiology ; Influenza, Human*/diagnosis ; Influenza, Human*/virology ; Pregnancy Complications, Infectious*/epidemiology ; Pregnancy Complications, Infectious*/diagnosis ; Antibodies, Viral*/blood ; Serologic Tests*/methods; Humans ; Female ; Pregnancy ; Adult ; Incidence ; Thailand/epidemiology ; Peru/epidemiology ; Young Adult ; Hemagglutination Inhibition Tests ; Influenza Vaccines/immunology ; Adolescent
    • Abstract:
      Background: We examined the added value of serologic testing for estimating influenza virus infection incidence based on illness surveillance with molecular testing versus periodic serologic testing.
      Methods: Pregnant persons unvaccinated against influenza at <28 weeks gestation were enrolled before the 2017 and 2018 influenza seasons in Peru and Thailand. Blood specimens were collected at enrollment and ≤14 days postpartum for testing by hemagglutination inhibition assay for antibodies against influenza reference viruses. Seroconversion was defined as a ≥4-fold rise in antibody titers from enrollment to postpartum with the second specimen's titer of ≥40. Throughout pregnancy, participants responded to twice weekly surveillance contacts asking about influenza vaccination and influenza-like symptoms (ILS). A mid-turbinate swab was collected with each ILS episode for influenza real-time reverse transcription polymerase chain reaction (rRT-PCR).
      Results: Of 1,466 participants without evidence of influenza vaccination during pregnancy, 296 (20.2%) had evidence of influenza virus infections. Fifteen (5.1%) were detected by rRT-PCR only, 250 (84.4%) by serologic testing only, and 31 (10.5%) by both methods.
      Conclusions: Influenza virus infections during pregnancy occurred in 20% of cohort participants; >80% were not detected by a broad illness case definition coupled with rRT-PCR.
      Competing Interests: Declarations of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
      (Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
    • Contributed Indexing:
      Keywords: Influenza; Peru; Pregnancy; Serology; Thailand
    • Accession Number:
      0 (Antibodies, Viral)
      0 (Influenza Vaccines)
    • Publication Date:
      Date Created: 20241019 Date Completed: 20241129 Latest Revision: 20241129
    • Publication Date:
      20241202
    • Accession Number:
      10.1016/j.ijid.2024.107264
    • Accession Number:
      39426491